Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy
- PMID: 1597243
- DOI: 10.1007/BF00175140
Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy
Abstract
Serial change of the metaiodobenzylguanidine iodine-123 (123I-MIBG) myocardial concentration was investigated in patients with dilated cardiomyopathy (DCM). Eight DCM patients and 6 control subjects were examined. After the injection of thallium-201 and 123I-MIBG, planar chest images were obtained simultaneously for both tracers in every 30-60 min over 5 h. Serial changes of myocardial uptake ratio (MUR) were compared for both tracers. In DCM, the initial MUR of 123I-MIBG did not differ significantly from that of the controls. The washout of 123I-MIBG from the myocardium, however, was significantly increased in DCM. In particular, the decrease in the early phase (15-45 min) was significantly larger in DCM than in the controls (21.2% +/- 7.5% vs. 5.3% +/- 4.0%, P less than 0.01), showing a significant negative correlation with the left ventricular ejection fraction (r = -0.72 P less than 0.05). For 201Tl, neither the initial MUR nor the washout rate different significantly between the two. Thus, an early rapid decrease of the 123I-MIBG myocardial concentration might characterize DCM and reflect the severity of this disease.
Similar articles
-
[Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy].Kaku Igaku. 1990 Jul;27(7):703-8. Kaku Igaku. 1990. PMID: 2232338 Japanese.
-
Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy.Nucl Med Commun. 1997 Mar;18(3):219-29. doi: 10.1097/00006231-199703000-00005. Nucl Med Commun. 1997. PMID: 9106775
-
Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.Clin Cardiol. 1997 Jan;20(1):61-6. doi: 10.1002/clc.4960200113. Clin Cardiol. 1997. PMID: 8994740 Free PMC article. Clinical Trial.
-
Clinical use of metaiodobenzylguanidine imaging in cardiology.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):29-39. Q J Nucl Med. 1995. PMID: 9002746 Review.
-
Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease.J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 2):S79-85. doi: 10.1007/BF02940073. J Nucl Cardiol. 1994. PMID: 9420702 Review.
Cited by
-
Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.J Nucl Cardiol. 1997 Sep-Oct;4(5):396-402. doi: 10.1016/s1071-3581(97)90031-3. J Nucl Cardiol. 1997. PMID: 9362016
-
Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy.Eur J Nucl Med. 1997 May;24(5):523-9. doi: 10.1007/BF01267684. Eur J Nucl Med. 1997. PMID: 9142733
-
Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.Int J Card Imaging. 1996 Dec;12(4):305-10. doi: 10.1007/BF01797744. Int J Card Imaging. 1996. PMID: 8993993
-
MIBG imaging.J Nucl Cardiol. 2002 Jan-Feb;9(1):75-94. doi: 10.1067/mnc.2002.121471. J Nucl Cardiol. 2002. PMID: 11845133 Review. No abstract available.
-
123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.Ann Nucl Med. 1996 Aug;10(3):315-21. doi: 10.1007/BF03164738. Ann Nucl Med. 1996. PMID: 8883707